Provided by Tiger Trade Technology Pte. Ltd.

Defiance Leveraged Long + Income HIMS ETF

5.43
0.0000
Volume:- -
Turnover:- -
Market Cap:2.71M
PE:- -
High:5.43
Open:5.43
Low:5.43
Close:5.43
52wk High:28.09
52wk Low:4.63
Shares:500.00K
Float Shares:500.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:5.56
Dividend Rate:102.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers completes acquisition of Eucalyptus parent Juniper platform

Reuters
·
Jun 02

Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

THOMSON REUTERS
·
Jun 02

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Its Position as the World’s Largest Consumer Health Platform

THOMSON REUTERS
·
Jun 02

Hims & Hers Health - Expands Benefits Program With Eight New Partners

THOMSON REUTERS
·
May 29

BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio

Reuters
·
May 27

BUZZ-U.S. STOCKS ON THE MOVE-MGM, Hims & Hers, Semtech

Reuters
·
May 27

BUZZ-Hims & Hers rises as board member boosts stake amid stock rout

Reuters
·
May 27

Hims & Hers Health Shares up 2.2% Premarket; Board Member David Wells Buys Nearly $1.2 Mln in Stock

THOMSON REUTERS
·
May 27

Can Hims & Hers (HIMS) Canadian GLP-1 Push Redefine Its Long-Term Profitability Playbook?

Simply Wall St.
·
May 27

Hims & Hers director David B. Wells reports purchase of 48,400 shares for $1.17 million

Reuters
·
May 27

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 27

Moderately bullish activity in Hims and Hers Health with shares down 0.32%

TIPRANKS
·
May 27

BUZZ-BofA says Hims & Hers 2026 revenue target hinges on GLP-1 growth, lowers PT

Reuters
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
May 22

Truist Adjusts Price Target on Hims & Hers Health to $23 From $18, Maintains Hold Rating

MT Newswires Live
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22